Yeytuo

Yeytuo (lenacapavir) is a long-acting antiretroviral medication used for HIV treatment and prevention. This injectable solution is designed for subcutaneous administration, offering sustained viral suppression. Ideal for patients seeking extended dosing intervals.

Lenacapavir is used to treat HIV-1 infection in adults and adolescents as part of combination therapy. It is also approved for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection in high-risk adults. This medication works by blocking HIV replication at multiple stages. People often ask, 'what is lenacapavir used for' or 'how does lenacapavir work for HIV prevention'.

Lenacapavir may cause injection site reactions such as pain, redness, or swelling. Some users report mild fatigue, nausea, or headache after administration. These effects are typically temporary and resolve within a few days. Most individuals tolerate the medication well during ongoing treatment.

Store lenacapavir in the refrigerator until use. Protect from light and avoid freezing. Do not use if the solution is discolored or contains particles. Always follow healthcare provider instructions for proper handling and disposal of injection supplies. Keep out of reach of children.

Lenacapavir may interact with strong CYP3A inhibitors or inducers, affecting its concentration. Avoid alcohol during treatment as it may worsen certain side effects. Consult a healthcare professional before combining with other medications. Grapefruit products may also alter lenacapavir levels.